Newt talks with Jonathan Dickinson, CEO and José Inzunza, Chief Medical Officer, Co-Founders of Ambio Life Sciences, a global leader in integrative ibogaine treatment.
Newt talks with Jonathan Dickinson, CEO and José Inzunza, Chief Medical Officer, Co-Founders of Ambio Life Sciences, a global leader in integrative Ibogaine treatment. They discuss the potential of Ibogaine as a therapy for post-traumatic stress disorder, opioid addiction, and depression. Ibogaine is classified as a Schedule I controlled substance by the U.S. Drug Enforcement Agency and is primarily administered in treatment facilities outside the U.S., such as in Mexico and Canada. They talk about their experiences administering Ibogaine and insights into its therapeutic effects, particularly the ability to mitigate opioid withdrawal symptoms and improve neurological health. They also highlight the importance of patient preparation and the need for ongoing support post-treatment to prevent relapse. Ambio Life Sciences collaborated with Stanford University and their pioneering clinical program for neurodegenerative diseases to study conditions like Parkinson’s and multiple sclerosis. Their discussion underscores Ibogaine’s potential to revolutionize addiction treatment and neurological health.
Follow and listen to more of Newt’s World:
Guest:
Jonathan Dickinson
José Inzunza
- Trying to Understand the Dance in the Persian Gulf
It will require a lot more patience and tolerance than is normal for the American people, the Congress, or the news media. - Democrats’ Socialist Surge Sets Up a Dilemma for Hakeem Jeffries
If he decides to legitimize the radicals, he will put every Democratic candidate in the country on the line. - The American People Want and Deserve Honest Elections
The emerging socialist, anti-American wing of the Democratic Party will make this issue even more important. - 12 Soldiers of the Revolution
In Washington, there is a remarkable new statue exhibit which helps bring this history alive. - Brexit and British Bankruptcy, Ten Years Later
British Independence could have triggered a turnaround, but it is hard now to see how Britain’s leaders can work their way out of the current cycle of decay.